RE:RE:RE:RE:RE:RE:RE:Scientific Notation LODYou really are scraping the bottom of the barrel. You are pushing Viemed who have nothing to do with testing and BD whose test is so inferior to Sona´s that it´s share price has risen the staggering amount of 6% since it was given FDA approval. The market speaks for itself. Sona jumped 122% on Validation and has risen more than double BD´s rise in the last few days with no news whatsover. GIVE UP YOU ARE FLOGGING A DEAD HORSE. Your efforts to short Sona are so obvious that they are truly pathetic. Compare sensitivity, ease of use, absence of a very limiting machine and cost and anyone, even you if you are honest, cannot but see tha vast difference between the 2 products. As I said the market speaks clearly and the market is not impressed with the BD offering while its´response to Sona´s recent progress is somewhat different.